RT Book, Section A1 Buys, Lucinda M. A1 Wiedenfeld, Sara A. A2 DiPiro, Joseph T. A2 Yee, Gary C. A2 Posey, L. Michael A2 Haines, Stuart T. A2 Nolin, Thomas D. A2 Ellingrod, Vicki SR Print(0) ID 1182450987 T1 Osteoarthritis T2 Pharmacotherapy: A Pathophysiologic Approach, 11e YR 2020 FD 2020 PB McGraw-Hill Education PP New York, NY SN 9781260116816 LK accesspharmacy.mhmedical.com/content.aspx?aid=1182450987 RD 2024/03/28 AB UPDATE SUMMARYThe following updates to this chapter were made on March 2, 2021.Table 106-2: Diclofenac 1.5% solution removed due to market discontinuation.Diagnosis section under Clinical Presentation corrected to clarify that no palpable warmth may be indicative of clinical diagnosis of knee osteoarthritis.Dosing and Administration section for Topical NSAIDs updated to include additional patient counseling points and to remove discussion of 1.5% diclofenac solutionPharmacoeconomic Impact of NSAIDs section updated to include discussion on cost comparison of prescription only topical NSAIDs.